March 2, 2026

Elemental Royalty upsizes revolving credit facility to US$150 million

Elemental Royalty Corporation has amended its revolving credit facility, increasing it to US$150 million with a US$50 million accordion feature. The facility, led by National Bank Capital Markets and CIBC..

Cooks Coffee Company’s Keith Jackson on strong growth and international expansion

Cooks Coffee Company highlights continued outperformance in the UK and Ireland, new retail partnerships with Tesco and Next, and master franchise agreements in the UAE and India as it builds..

Asia small-cap investing beyond growth stories and risk myths

Long-term market history and hands-on research challenge common assumptions about Asia small-cap investing, revealing how disciplined valuation and business quality have driven returns over time...

TEAM plc CIO Craig Farley on 2025 market resilience and positioning for 2026

Craig Farley, CIO of TEAM plc, reviews 2025’s market recovery, explains the firm’s barbell equity and fixed income positioning, and highlights key risks for 2026 including hyperscaler AI spending, geopolitical..

FTSE 100 Falls as Oil Spike and Geopolitical Tensions Weigh on Risk Appetite

FTSE 100 declines as oil prices jump on geopolitical tensions, pressuring travel and banking stocks while energy shares limit losses...

Assessing China’s AI momentum one year after DeepSeek

One year after the launch of DeepSeek, China’s renewed AI momentum raises a key question for investors: does it reflect short-term enthusiasm or a deeper structural shift? With Chinese equities..

Inspire Medical Systems, Inc. (INSP): Evaluating Growth Potential in the Medical Device Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP), a prominent player in the healthcare sector specializing in medical devices, is making waves with its innovative solutions for obstructive sleep apnea (OSA). As..

Regencell Bioscience Holdings L (RGC): Unpacking the High Volatility and Unique Market Position in TCM

Regencell Bioscience Holdings Limited (NASDAQ: RGC) presents a unique investment opportunity with its distinct focus on Traditional Chinese Medicine (TCM) for neurocognitive disorders. Based in Hong Kong, this specialty drug..

Teleflex Incorporated (TFX) Stock Analysis: Insights on Potential Upside and Analyst Ratings

Teleflex Incorporated (NYSE: TFX), a dominant player in the healthcare sector, specializes in the design, development, and manufacture of single-use medical devices used in critical care and surgical applications. With..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A Biotech with a 46.52% Potential Upside

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, is capturing investor attention with a potential upside of 46.52% based on current analyst projections. Known for its focus..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Exploring a 195% Potential Upside for Biotechnology Investors

Telix Pharmaceuticals Limited (ASX: TLX), a prominent player in the biopharmaceutical landscape, presents a compelling opportunity for investors with its innovative approach to developing therapeutic and diagnostic radiopharmaceuticals. Despite its..

Atrium Therapeutics, Inc. (RNA): An Insightful Analysis of a Biotech Challenger with a $2.28 Billion Market Cap

Atrium Therapeutics, Inc. (RNA) presents a compelling narrative in the biotech sector, driven by its innovative approach to RNA therapeutics aimed at transforming cardiac care. With a market capitalization of..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a 208.93% Potential Upside in Pioneering Biotech Ventures

Legend Biotech Corporation (NASDAQ: LEGN) stands out in the biotechnology sector, not only for its innovative advancements in cell therapy but also for its striking potential upside of 208.93%, as..

DaVita Inc. (DVA) Stock Analysis: Evaluating Growth Potential Amid a 64.85% Return on Equity

DaVita Inc. (DVA), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is making waves with its impressive return on equity (ROE) of 64.85%. This..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Promising Genetic Medicine Leader with 13.63% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) is a burgeoning player in the biotechnology sector, making significant strides in the genetic medicine landscape. With a market cap of $8.06 billion, this Pittsburgh-based..

Glaukos Corporation (GKOS) Stock Analysis: Potential 11.95% Upside Amid Robust Revenue Growth

Glaukos Corporation (NYSE: GKOS), a notable player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with its innovative therapies targeting ophthalmic conditions. With a..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating Growth with a 7.05% Potential Upside

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, continues to make strides in the competitive landscape of oncology treatment. With a focus on developing and commercializing novel..

TransMedics Group, Inc. (TMDX) Stock Analysis: Strong Growth with a 54.24% Return on Equity

TransMedics Group, Inc. (Nasdaq: TMDX) is rapidly gaining attention in the healthcare sector, specifically in the medical devices industry. The company is revolutionizing organ transplant therapy with its innovative Organ..

Oscar Health, Inc. (OSCR) Investor Outlook: Navigating a Potential 12.9% Upside Amid Mixed Analyst Ratings

Oscar Health, Inc. (OSCR), a healthcare technology company headquartered in New York, is garnering attention from investors due to its innovative approach to healthcare plans and its intriguing potential for..

BeOne Medicines Ltd. (ONC) Stock Analysis: 29.95% Potential Upside in Oncology Innovation

BeOne Medicines Ltd. (ONC), a Swiss-based biotech powerhouse, is capturing investors’ attention with its robust oncology-focused pipeline and impressive revenue growth. With a market capitalization of $35.08 billion, this healthcare..

Search

Funds

March 2, 2026

Elemental Royalty upsizes revolving credit facility to US$150 million

Elemental Royalty Corporation has amended its revolving credit facility, increasing it to US$150 million with a US$50 million accordion feature. The facility, led by National Bank Capital Markets and CIBC with National Bank of Canada as administrative agent, matures in February 2029 and is intended to support future royalty and streaming transactions...

Cooks Coffee Company’s Keith Jackson on strong growth and international expansion

Cooks Coffee Company highlights continued outperformance in the UK and Ireland, new retail partnerships with Tesco and Next, and master franchise agreements in the UAE and India as it builds long-term international growth...

Asia small-cap investing beyond growth stories and risk myths

Long-term market history and hands-on research challenge common assumptions about Asia small-cap investing, revealing how disciplined valuation and business quality have driven returns over time...

TEAM plc CIO Craig Farley on 2025 market resilience and positioning for 2026

Craig Farley, CIO of TEAM plc, reviews 2025’s market recovery, explains the firm’s barbell equity and fixed income positioning, and highlights key risks for 2026 including hyperscaler AI spending, geopolitical tensions, and a potential second wave of inflation...

FTSE 100 Falls as Oil Spike and Geopolitical Tensions Weigh on Risk Appetite

FTSE 100 declines as oil prices jump on geopolitical tensions, pressuring travel and banking stocks while energy shares limit losses...

Assessing China’s AI momentum one year after DeepSeek

One year after the launch of DeepSeek, China’s renewed AI momentum raises a key question for investors: does it reflect short-term enthusiasm or a deeper structural shift? With Chinese equities having rallied strongly, attention is turning to what has genuinely changed, and what this means for portfolio positioning...
Search

Funds

March 2, 2026

FTSE 100

Funds